Key Highlights: Implications: For Novartis India, bringing these brands back in‑house supports a more controlled go‑to‑market under new PE ownership and aligns with its plan to insta...
Key Highlights: Implication: This divestment signals multinational pharma firms accelerating exits from legacy India operations, potentially pressuring peers like Roche and Sanofi to restructure...
